Mark K. Lafferty - Concepedia

Author

Mark K. Lafferty

University of Maryland, Baltimore

Also Known As

M.K. Lafferty, Mark K Lafferty, Mark K. Lafferty, Mark Lafferty

Publications

415

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore University of Padua Institute of Human Virology Johns Hopkins University

About

Mark K. Lafferty is an author at University of Maryland, Baltimore specializing in hiv, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	92
2	Immunology	3	3	92
3	Cell Biology	2	2	57
4	Pathology	2	2	57
5	Autoimmune Disease	2	2	72

Mark K. Lafferty

Publications

408

Citations

H-Index

Page 1

	Year	Citations
Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients Clara Lehmann, Mark K. Lafferty, Alfredo Garzino‐Demo, PLoS ONE	2010	90
Human T <sub>h</sub> 17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection Aaron Christensen-Quick, Mark K. Lafferty, Lingling Sun, Journal of Virology	2016	59
CCR6 ligands inhibit HIV by inducing APOBEC3G Mark K. Lafferty, Lingling Sun, Leon DeMasi, Blood	2009	47
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases Fiorenza Cocchi, Anthony L. DeVico, Wuyuan Lu, Proceedings of the National Academy of Sciences	2012	43
B cell lymphoma in hiv transgenic mice Sabrina Curreli, Selvi Krishnan, Marvin S. Reitz, Retrovirology	2013	38
Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice Virginia Carroll, Mark K. Lafferty, Luigi Marchionni, Proceedings of the National Academy of Sciences Immune RegulationImmunologyImmunodominancePathologyHuman Retrovirus	2016	37
Increased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease Anjana Yadav, Phillip Fitzgerald, Mohammad M. Sajadi, Virology Autoimmune DiseaseHiv-1 DiseaseHuman RetrovirusT-regulatory CellImmunology	2009	35
Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6+CD4+ T Cells Mark K. Lafferty, Lingling Sun, Aaron Christensen-Quick, Viruses	2017	28
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17 Daniele Basta, Olga Latinovic, Mark K. Lafferty, Pathogens and Disease InflammationAngiogenesisHuman RetrovirusImmunologyAdipogenic Effects	2015	20
Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic rats Mark K. Lafferty, Lori E. Fantry, Joseph Bryant, Pathogens and Disease	2013	11

Page 1